Thermo Fisher Scientific Bioproduction Articles

1. A Paradigm Shift From Glass Benchtop Bioreactors 8/14/2025

   Learn how a bench-scale single-use bioreactor offers process development advantages over traditional glass systems, including higher efficiency, increased productivity, and enhanced sustainability.

2. Scalability From 5L To 50L Using The DynaDrive Single-Use Bioreactor 8/14/2025

   Maintaining a consistent bioprocess when scaling from 5 L to 50 L is achievable. This study shows how to successfully scale processes while maintaining cell density, viability, and protein production.

3. Consistent Improvement In CHO-K1 GS Performance With Efficient-Pro Feed 3 And Efficient-Pro Feed Enhancer 7/21/2025

   Optimize your CHO-K1 GS cell line with advanced chemically defined, animal origin-free feeds. Achieve higher titers and reliable product quality.

4. The Value Of Peptones For Cost-Effective Vaccine Manufacturing 6/16/2025

   Peptones offer a strategic solution to key biomanufacturing challenges by enhancing cell culture performance, improving yields, and reducing production costs.

5. Improved T Cell Expansion Using Closed, Automated Stirred-Tank Bioreactors 6/10/2025

   A shift from traditional rocking motion systems to stirred-tank bioreactors can enhance T cell expansion, offering greater scalability and more intimate process control.

6. Comparing Serum-free To Serum-Supplemented Media 6/9/2025

   Reducing serum in vaccine manufacturing is a key consideration for lowering costs and improving supply security. We compare performance in serum-free versus serum-supplemented media.

7. A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications 6/9/2025

   Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

8. Streamline Your mAb Manufacturing With Strategic Development And CDMO Compatibility 6/4/2025

   Though the journey to mAb development begins at lab scale, for clinical trials and commercial distribution, a production process must be streamlined and scalable to 2,000 L production and above.

9. The Role Of Peptones In Boosting Monoclonal Antibody Production 5/9/2025

   Peptones have become a key tool in CHO cell bioprocessing, enhancing monoclonal antibody yield and quality.

10. Optimize Your Approach To mAb Development 4/4/2025

    To meet the growing demand for mAbs and their variants, it is important to leverage opportunities for optimization as well as work with suppliers that have the resources to help your workflow thrive.